<p>卡路美（Calumet Specialty Products Partners, L.P.）（NASDAQ:CLMT - 獲取免費報告）在週一的交易中上漲了 4.6%。該公司的股價最高達到 10.93 美元，最後交易價為 10.97 美元。在交易中，共成交 38,669 股，較平均交易量 831,847 股下降了 95%。該股票此前收盤價為 10.48 美元。</p>
<h2>華爾街分析師觀點</h2>
<ul>
<li>2 只能源股因十億美元的能源部貸款承諾而飆升</li>
</ul>
<p>幾位股票研究分析師最近對 CLMT 股票發表了看法。富國銀行將卡路美的股票目標價從 28.00 美元下調至 23.00 美元，並在 4 月 9 日的研究報告中給予該公司 “增持” 評級。瑞銀集團將卡路美的評級從 “賣出” 上調至 “中性”，並在 3 月 17 日的報告中將其目標價從 15.00 美元下調至 12.00 美元。HC Wainwright 在 3 月 3 日的報告中重申了 “買入” 評級，並對卡路美的股票設定了 33.00 美元的目標價。最後，TD Cowen 將卡路美的評級從 “買入” 下調至 “持有”，並在 3 月 4 日的報告中將其目標價從 26.00 美元下調至 16.00 美元。一位分析師對該股票給予了 “賣出” 評級，兩位分析師給予了 “持有” 評級，三位分析師給予了 “買入” 評級。根據 MarketBeat 的數據，該公司目前的共識評級為 “持有”，共識目標價為 19.80 美元。</p>
<p><strong>查看我們對 CLMT 的最新分析</strong></p>
<h2>卡路美股票上漲 4.7%</h2>
<p>該公司的 50 日簡單移動平均線為 11.90 美元，200 日簡單移動平均線為 17.24 美元。公司的市值為 9.428 億美元，市盈率為-3.97，貝塔值為 1.42。</p>
<p>卡路美（Calumet Specialty Products Partners）（NASDAQ:CLMT - 獲取免費報告）最近於 2 月 28 日發佈了其財報。這家石油和天然氣公司報告本季度每股收益（EPS）為-0.47 美元，超出分析師一致預期的-1.06 美元，超出幅度為 0.59 美元。該季度的營業收入為 9.495 億美元，而分析師預期為 9.2176 億美元。去年同期，該公司每股收益為-0.59 美元。卡路美本季度的收入同比下降了 2.8%。分析師預計卡路美將在本財年發佈-3.02 美元的每股收益。</p>
<h2>內部交易活動</h2>
<p>在其他卡路美的新聞中，首席財務官 David Lunin 於 3 月 4 日（星期二）購買了 2,500 股該公司的股票，交易價格為每股 13.05 美元，總價值為 32,625.00 美元。交易完成後，首席財務官現在直接持有該公司 2,500 股股票，價值 32,625 美元。這筆交易代表了其持股的∞增長。該購買在向 SEC 提交的文件中披露，相關文件可通過 SEC 網站訪問。此外，董事 Stephen P. Mawer 於 3 月 24 日（星期一）出售了 3,655 股該公司的股票，交易價格為每股 12.88 美元，總交易額為 47,076.40 美元。出售後，該董事現在直接持有 287,307 股該公司股票，價值 3,700,514.16 美元。這筆交易代表了其持股的 1.26% 減少。該出售的披露信息可以在這裏找到。公司內部人士目前持有該股票的 2.91%。</p>
<h2>關於卡路美</h2>
<p>（獲取免費報告）</p>
<p>卡路美公司從事多樣化的特種品牌產品和可再生燃料的製造、配方和營銷，客户涵蓋廣泛的消費市場和工業市場。它通過以下幾個部門運營：特種產品與解決方案、性能品牌、蒙大拿州/可再生能源和公司業務。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過卡路美</li>
<li>超買股票解析：你應該交易它們嗎？</li>
<li>2025 年最佳防禦股票... 到目前為止</li>
<li>投資石油股票的方式和原因</li>
<li>字母表在強勁財報和回購公告後反彈</li>
<li>3 只值得考慮的股息王</li>
<li>出售台積電會是巴菲特最大的遺憾嗎？</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在卡路美嗎？</h2>
<p>在考慮卡路美之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前進行購買... 而卡路美並不在名單上。</p>
<p>雖然卡路美目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

卡路美

<p>Calumet Specialty Products Partners（納斯達克代碼：CLMT）股價上漲 4.6%，至 10.97 美元，儘管交易量顯著下降。分析師意見不一，富國銀行將其目標價下調至 23.00 美元，而 HC Wainwright 則維持買入評級，目標價為 33.00 美元。該公司報告的季度每股收益為（0.47 美元），超出預期，但收入同比下降 2.8%。內部交易活動包括首席財務官 David Lunin 購買股票，而董事 Stephen P. Mawer 則出售了一部分持股。該股票的共識評級為 “持有”，目標價為 19.80 美元</p>

<p>Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) shot up 4.6% during trading on Monday . The company traded as high as $10.93 and last traded at $10.97. 38,669 shares traded hands during trading, a decline of 95% from the average session volume of 831,847 shares. The stock had previously closed at $10.48.</p>
<div class="lb-trans"><p>卡路美（Calumet Specialty Products Partners, L.P.）（NASDAQ:CLMT - 獲取免費報告）在週一的交易中上漲了 4.6%。該公司的股價最高達到 10.93 美元，最後交易價為 10.97 美元。在交易中，共成交 38,669 股，較平均交易量 831,847 股下降了 95%。該股票此前收盤價為 10.48 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><ul>
<li>2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只能源股因十億美元的能源部貸款承諾而飆升</li>
</ul>
</div><p>Several equities research analysts have recently weighed in on CLMT shares. Wells Fargo &amp; Company lowered their price target on shares of Calumet Specialty Products Partners from $28.00 to $23.00 and set an &#34;overweight&#34; rating for the company in a research report on Wednesday, April 9th. UBS Group upgraded Calumet Specialty Products Partners from a &#34;sell&#34; rating to a &#34;neutral&#34; rating and lowered their target price for the stock from $15.00 to $12.00 in a report on Monday, March 17th. HC Wainwright reiterated a &#34;buy&#34; rating and issued a $33.00 target price on shares of Calumet Specialty Products Partners in a report on Monday, March 3rd. Finally, TD Cowen downgraded Calumet Specialty Products Partners from a &#34;buy&#34; rating to a &#34;hold&#34; rating and lowered their price target for the company from $26.00 to $16.00 in a report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $19.80.</p>
<div class="lb-trans"><p>幾位股票研究分析師最近對 CLMT 股票發表了看法。富國銀行將卡路美的股票目標價從 28.00 美元下調至 23.00 美元，並在 4 月 9 日的研究報告中給予該公司 “增持” 評級。瑞銀集團將卡路美的評級從 “賣出” 上調至 “中性”，並在 3 月 17 日的報告中將其目標價從 15.00 美元下調至 12.00 美元。HC Wainwright 在 3 月 3 日的報告中重申了 “買入” 評級，並對卡路美的股票設定了 33.00 美元的目標價。最後，TD Cowen 將卡路美的評級從 “買入” 下調至 “持有”，並在 3 月 4 日的報告中將其目標價從 26.00 美元下調至 16.00 美元。一位分析師對該股票給予了 “賣出” 評級，兩位分析師給予了 “持有” 評級，三位分析師給予了 “買入” 評級。根據 MarketBeat 的數據，該公司目前的共識評級為 “持有”，共識目標價為 19.80 美元。</p>
</div><p><strong>View Our Latest Analysis on CLMT</strong></p>
<div class="lb-trans"><p><strong>查看我們對 CLMT 的最新分析</strong></p>
</div><h2>Calumet Specialty Products Partners Stock Up 4.7 %</h2>
<div class="lb-trans"><h2>卡路美股票上漲 4.7%</h2>
</div><p>The firm's 50 day simple moving average is $11.90 and its 200 day simple moving average is $17.24. The company has a market cap of $942.80 million, a price-to-earnings ratio of -3.97 and a beta of 1.42.</p>
<div class="lb-trans"><p>該公司的 50 日簡單移動平均線為 11.90 美元，200 日簡單移動平均線為 17.24 美元。公司的市值為 9.428 億美元，市盈率為-3.97，貝塔值為 1.42。</p>
</div><p>Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.06) by $0.59. The business had revenue of $949.50 million during the quarter, compared to analysts' expectations of $921.76 million. During the same quarter in the previous year, the company earned ($0.59) EPS. Calumet Specialty Products Partners's revenue for the quarter was down 2.8% on a year-over-year basis. Analysts anticipate that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>卡路美（Calumet Specialty Products Partners）（NASDAQ:CLMT - 獲取免費報告）最近於 2 月 28 日發佈了其財報。這家石油和天然氣公司報告本季度每股收益（EPS）為-0.47 美元，超出分析師一致預期的-1.06 美元，超出幅度為 0.59 美元。該季度的營業收入為 9.495 億美元，而分析師預期為 9.2176 億美元。去年同期，該公司每股收益為-0.59 美元。卡路美本季度的收入同比下降了 2.8%。分析師預計卡路美將在本財年發佈-3.02 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部交易活動</h2>
</div><p>In other Calumet Specialty Products Partners news, CFO David Lunin acquired 2,500 shares of the business's stock in a transaction dated Tuesday, March 4th. The shares were acquired at an average price of $13.05 per share, with a total value of $32,625.00. Following the completion of the transaction, the chief financial officer now directly owns 2,500 shares in the company, valued at $32,625. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Stephen P. Mawer sold 3,655 shares of the company's stock in a transaction on Monday, March 24th. The stock was sold at an average price of $12.88, for a total transaction of $47,076.40. Following the sale, the director now directly owns 287,307 shares in the company, valued at $3,700,514.16. This trade represents a 1.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.91% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他卡路美的新聞中，首席財務官 David Lunin 於 3 月 4 日（星期二）購買了 2,500 股該公司的股票，交易價格為每股 13.05 美元，總價值為 32,625.00 美元。交易完成後，首席財務官現在直接持有該公司 2,500 股股票，價值 32,625 美元。這筆交易代表了其持股的∞增長。該購買在向 SEC 提交的文件中披露，相關文件可通過 SEC 網站訪問。此外，董事 Stephen P. Mawer 於 3 月 24 日（星期一）出售了 3,655 股該公司的股票，交易價格為每股 12.88 美元，總交易額為 47,076.40 美元。出售後，該董事現在直接持有 287,307 股該公司股票，價值 3,700,514.16 美元。這筆交易代表了其持股的 1.26% 減少。該出售的披露信息可以在這裏找到。公司內部人士目前持有該股票的 2.91%。</p>
</div><h2>About Calumet Specialty Products Partners</h2>
<div class="lb-trans"><h2>關於卡路美</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products &amp; Solutions, Performance Brands, Montana/Renewables, and Corporate.</p>
<div class="lb-trans"><p>卡路美公司從事多樣化的特種品牌產品和可再生燃料的製造、配方和營銷，客户涵蓋廣泛的消費市場和工業市場。它通過以下幾個部門運營：特種產品與解決方案、性能品牌、蒙大拿州/可再生能源和公司業務。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Calumet Specialty Products Partners</li>
<li>Overbought Stocks Explained: Should You Trade Them?</li>
<li>Best Defense Stocks in 2025... So Far</li>
<li>The How And Why of Investing in Oil Stocks</li>
<li>Alphabet Rebounds After Strong Earnings and Buyback Announcement</li>
<li>3 Dividend Kings To Consider</li>
<li>Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過卡路美</li>
<li>超買股票解析：你應該交易它們嗎？</li>
<li>2025 年最佳防禦股票... 到目前為止</li>
<li>投資石油股票的方式和原因</li>
<li>字母表在強勁財報和回購公告後反彈</li>
<li>3 只值得考慮的股息王</li>
<li>出售台積電會是巴菲特最大的遺憾嗎？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在卡路美嗎？</h2>
</div><p>Before you consider Calumet Specialty Products Partners, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮卡路美之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前進行購買... 而卡路美並不在名單上。</p>
</div><p>While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然卡路美目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

卡路美特種產品合夥公司（納斯達克代碼：CLMT）股價上漲 4.6% - 仍然是買入的好時機嗎？